| REVIEW ARTICLE |
|
| Year : 2023 | Volume
: 17
| Issue : 2 | Page : 223-235 |
|
|
Sedation for adult ICU patients: A narrative review including a retrospective study of our own data
David De Bels1, Ibrahim Bousbiat1, Emily Perriens1, Sydney Blackman1, Patrick M Honoré2
1 Intensive Care Unit, Brugmann University Hospital, Brussels, Belgium
2 Department of Intensive Care, CHU UCL Godinne Namur, UCL Louvain Medical School, Yvoir, Belgium
Correspondence Address:
Patrick M Honoré
Intensive Care Department, CHU UCL Godinne Namur, UCL Louvain Medical School, 1, Avenue Dr. G Therasse, 5530 Yvoir (Namur)
Belgium
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/sja.sja_905_22
|
|
|
The optimization of patients' treatment in the intensive care unit (ICU) needs a lot of information and literature analysis. Many changes have been made in the last years to help evaluate sedated patients by scores to help take care of them. Patients were completely sedated and had continuous intravenous analgesia and neuromuscular blockades. These three drug classes were the main drugs used for intubated patients in the ICU. During these last 20 years, ICU management went from fully sedated to awake, calm, and nonagitated patients, using less sedatives and choosing other drugs to decrease the risks of delirium during or after the ICU stay. Thus, the usefulness of these three drug classes has been challenged. The analgesic drugs used were primarily opioids but the use of other drugs instead is increasing to lessen or wean the use of opioids. In severe acute respiratory distress syndrome patients, neuromuscular blocking agents have been used frequently to block spontaneous respiration for 48 hours or more; however, this has recently been abolished. Optimizing a patient's comfort during hemodynamic or respiratory extracorporeal support is essential to reduce toxicity and secondary complications.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
